低透析液钠浓度对透析中高血压患者48小时动态血压的影响:随机交叉研究
本研究为随机单盲交叉研究,纳入29例透析中高血压(IDH)患者,比较低钠(137 mEq/L)与标准钠(140 mEq/L)透析液对48小时血压的影响。结论支持低透析液钠作为IDH患者血压管理的非药物手段。
要点
- 低透析液钠(137 mEq/L)较标准钠(140 mEq/L)显著降低IDH患者48小时动态血压。
- 低钠透析液还降低透析后及透析中血压,并减少透析前体重、IDWG和B线。
- 低透析液钠可作为IDH患者血压管理的非药物策略。
核心结论
- 在IDH患者中,低透析液钠浓度(137 mEq/L)较标准浓度(140 mEq/L)显著降低48小时动态血压。
研究设计与样本
- 随机、单盲、交叉研究,纳入29例IDH患者,分别接受4次低钠(137 mEq/L)和4次标准钠(140 mEq/L)透析液透析。
主要发现
- 低钠透析液还显著降低透析前体重、IDWG和透析前B线。
临床怎么用
- 对于IDH患者,可考虑使用低透析液钠浓度(137 mEq/L)作为非药物降压策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intradialytic hypertension (IDH) is associated with increased risk for cardiovascular events and mortality. Patients with IDH exhibit higher 48-h blood pressure (BP) levels than patients without this condition. Volume and sodium excess are considered a major factor contributing in the development of this phenomenon. This study evaluated the effect of low (137 mEq/L) compared with standard (140 mEq/L) dialysate sodium concentration on 48-h BP in patients with IDH. METHODS: In this randomized, single-blind, crossover study, 29 patients with IDH underwent four hemodialysis sessions with low (137 mEq/L) followed by four sessions with standard (140 mEq/L) dialysate sodium, or vice versa. Mean 48-h BP, pre-/post-dialysis and intradialytic BP, pre-dialysis weight, interdialytic weight gain (IDWG) and lung ultrasound B-lines were assessed. RESULTS: Mean 48-h systolic/diastolic BP (SBP/DBP) were significantly lower with low compared with standard dialysate sodium concentration (137.6 ± 17.0/81.4 ± 13.7 mmHg with low vs 142.9 ± 14.5/84.0 ± 13.9 mmHg with standard dialysate sodium, P = .005/P = .007, respectively); SBP/DBP levels were also significantly lower during the 44-h and different 24-h periods. Low dialysate sodium significantly reduced post-dialysis (SBP/DBP: 150.3 ± 22.3/91.2 ± 15.1 mmHg with low vs 166.6 ± 17.3/94.5 ± 14.9 mmHg with standard dialysate sodium, P < .001/P = .134, respectively) and intradialytic (141.4 ± 18.0/85.0 ± 13.4 mmHg with low vs 147.5 ± 13.6/88.1 ± 12.5 mmHg with standard dialysate sodium, P = .034/P = .013, respectively) BP compared with standard dialysate sodium. Pre-dialysis weight, IDWG and pre-dialysis B lines were also significantly decreased with low dialysate sodium. CONCLUSIONS: Low dialysate sodium concentration significantly reduced 48-h ambulatory BP compared with standard dialysate sodium in patients with IDH. These findings support low dialysate sodium as a major non-pharmacologic approach for BP management in patients with IDH. TRIAL REGISTRATION: ClinicalTrials.gov study number NCT05430438.
引用
- Iatridi F, Malandris K, Ekart R, et al. Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study. Nephrol Dial Transplant. 2024. PMID: 38710537. doi:10.1093/ndt/gfae104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。